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S U M M A R Y
Objectives: This study sought to document the clinical and laboratory manifestations, genetic variability,
and outcomes of scrub typhus, an often severe infection caused by Orientia tsutsugamushi, in South India.
Methods: Patients admitted to a large teaching hospital with IgM ELISA-conﬁrmed scrub typhus were
evaluated. Clinical examination with a thorough search for an eschar, laboratory testing, chest X-ray, and
outcome were documented and analyzed. Additionally, a 410-bp region of the 56-kDa type-speciﬁc
antigen gene of O. tsutsugamushi was sequenced and compared with isolates from other regions of Asia.
Results: Most of the 154 patients evaluated presented with fever and non-speciﬁc symptoms. An eschar
was found in 86 (55%) patients. Mild hepatic involvement was seen in most, with other organ
involvement including respiratory, cardiovascular, and renal. Multi-organ dysfunction was noted in 59
(38.3%), and the fatality rate was 7.8%. Hypotension requiring vasoactive agents was found to be an
independent predictor of mortality (p < 0.001). The phylogeny of 26 samples showed 17 (65%) clustering
with the Kato-like group and eight (31%) with the Karp-like group.
Conclusions: The presentation of scrub typhus can be variable, often non-speciﬁc, but with potentially
severe multi-organ dysfunction. Prompt recognition is key to speciﬁc treatment and good outcomes.
Further study of the circulating strains is essential for the development of a successful vaccine and
sensitive point-of-care testing.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Scrub typhus is a re-emerging zoonotic bacterial infection in the
region known as the ‘tsutsugamushi triangle’ of South and
Southeast Asia, the Asian Paciﬁc rim, and Northern Australia.1–3
The causative organism, Orientia tsutsugamushi, is transmitted to
humans by the bite of the larval stage (chigger) of the trombiculid
mites, most commonly Leptotrombidium deliense. O. tsutsugamushi
is a Gram-negative, obligate intracellular bacterium that infects
various cells, including endothelial cells and phagocytes, causing
acute vasculitis. Clinical manifestations include an acute onset of
fever, headache, myalgia, multiple organ dysfunction, and an* Corresponding author. Tel.: +91 9487393015; fax: +0416 2232035.
E-mail address: georgemvarghese@hotmail.com (G.M. Varghese).
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http://dx.doi.org/10.1016/j.ijid.2013.05.017eschar at the site of inoculation, which is present in a variable
proportion of patients. It can range in severity from a mild, self-
limiting disease to, if untreated, a fatal illness in 30–50% of those it
affects.4 Previous reports have loosely classiﬁed these varied
presentations as: mild disease, respiratory-predominant disease,
central nervous system-predominant disease (meningioencepha-
litis), or sepsis syndrome.5 The clinical manifestations of cases
reported from India show variability when compared to those from
other endemic Asian countries.6 This could be due to differences in
the infecting strains, which are known to have a high level of
antigenic variation. Antigenic variation is primarily due to
differences in the 56-kDa type-speciﬁc antigen (TSA).
The 56-kDa TSA is a transmembrane protein, likely involved in
adherence to and invasion of target cells. It is unique to the Orientia
genus, and is one of the major attributes for its exclusion from the
Rickettsia genus.7 Within the genus itself, however, the protein isses. Published by Elsevier Ltd. All rights reserved.
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basis for strain differentiation.8 Initially, serologic testing (via
complement ﬁxation), based largely on this protein, was used to
identify the original Gilliam, Karp, and Kato ‘prototype’ strains.9
However, since then, over 20 unique types have been identiﬁed
and arranged into ‘clusters’, initially using further serologic testing
and then the genetic sequences of this unique protein. Sequencing
of this section of the organism’s genome has shown that there are
four variable domains (VD I–IV), coding for four hydrophilic
regions of this protein.10,11 Recent efforts to catalog the strains
present at various locations have shown that novel subtypes
continue to emerge. A recent phylogenetic analysis of O.
tsutsugamushi from Taiwan reported two unique sequence types
along with Karp-related, Saitama, JG-related, and Kuroki-related
genotypes.12 Multi-locus sequence typing (MLST) analysis of Thai
isolates has shown a very high rate of recombination, which along
with gene duplication and horizontal transfer accounts for the
genetic diversity among O. tsutsugamushi isolates.13,14 In 2008, ﬁve
O. tsutsugamushi clades were reported to be circulating in
Cambodia and three in Vietnam, with high genetic diversity.15
In 2011, several isolates, newly characterized from Thailand, were
found to be related to Kato and Karp strains.16 The prevalence of
new Karp-like and Kato-like strains is now being reported widely
and requires further analysis.3,17 However, despite this growing
knowledge of strain epidemiology and phylogeny in endemic
regions, there is a true paucity of information from India.1
Although there have been a few scattered reports, there is still
too little data to create a comprehensive picture of this populous
country that is broadly affected by this re-emerging infec-
tion.3,5,18,19 Therefore, in addition to describing the clinical and
laboratory manifestations and outcome of the disease, the
objectives of this study included describing the genotypes of O.
tsutsugamushi and comparing these isolates to those from other
affected regions.
2. Methods
Patients over 15 years of age admitted with scrub typhus to the
Christian Medical College, Vellore, a 2700-bed medical college
hospital, between August 2009 and October 2010, were included in
the study. Scrub typhus had to be conﬁrmed by IgM ELISA; patients
with and without an eschar were included. The study was
approved by the Institutional Review Board and Ethics Committee,
and informed consent was obtained. A detailed clinical examina-
tion, including a careful search for an eschar, was documented for
each patient. Basic laboratory studies were performed, including a
complete blood count, creatinine, glucose, liver function tests, and
chest X-rays; additional investigations were performed when
indicated, and included blood cultures, quantitative buffy coat
(QBC) testing for malarial parasites, abdominal ultrasound, and
serology for leptospirosis and dengue. IgM ELISA was performed on
serum samples using Scrub Typhus Detect (InBios International,
Inc., Seattle, WA, USA) as per the manufacturer’s instructions. An
optical density (OD) >0.5 was considered positive.
2.1. PCR analysis
Eschar samples used for PCR were collected and stored in
absolute ethanol at 80 8C until use. Bacterial DNA, extracted using
a QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) in accordance
with the manufacturer’s instructions, was used as the template for
the PCR. A standard PCR targeting the 56-kDa protein was carried
out on 35 representative eschar samples as reported previously.3,17
The expected amplicon size was 410 bp. The oligonucleotide
primers used were as follows: forward OtsuF: 50-AATTGCTAGTG-
CAATGTCTG-30; reverse OtsuR: 50-GGCATTATAGTAGGCTGAG-30.The PCR ampliﬁcation mixture (ﬁnal volume 50 ml) contained
1.5 mM MgCl2, 50 mM KCl, 10 mM Tris–HCl (pH 8.3), 200 mM each
of dATP, dGTP, dCTP, and dTTP, 0.2 mM of primers, and 1 U of Taq
DNA polymerase (Boehringer Mannheim, Germany). The reaction
was carried out in a DNA thermal cycler (MJ Research, USA).
Ampliﬁcation consisted of 40 cycles, which included denaturation
at 94 8C for 30 s, annealing at 57 8C for 1 min, and extension at 72 8C
for 1 min. The PCR products were electrophoresed in 1.5% agarose
gels, and the gel containing DNA fragments was stained with
0.5 mg/ml of ethidium bromide and visualized by ultraviolet
transillumination (BioRad Inc., USA).
2.2. DNA sequencing
Twenty-six selected amplicons were subsequently puriﬁed
using the QIAquick PCR Puriﬁcation Kit (Qiagen) as per the
manufacturer’s instructions. Sequencing reactions were done
using the Big Dye Terminator Cycle Sequencing Kit (Applied
Biosystems, Foster City, CA, USA), followed by enumeration on an
ABI 310 Genetic Analyzer (Applied Biosystems, Foster City, CA,
USA). The sequences were edited using FinchTV (Geospiza Inc.),
and phylogenetic and molecular evolutionary analyses were
conducted using MEGA version 5.20 The phylogenetic tree with
1000 bootstrap replicates was constructed using the neighbor-
joining method and the distances calculated using the maximum
composite likelihood method. The sequences obtained were
identiﬁed by comparison with sequences available in GenBank
using BLAST software (http://blast.ncbi.nlm.nih.gov). Good se-
quence reads were obtained for 25 eschar samples and the
sequences have been submitted to GenBank (accession numbers
KC153061–KC153085).
2.3. Statistical methods
The statistical analysis was performed using SPSS software for
Windows version 16.0 (SPSS Inc., Chicago, IL, USA). Descriptive
data are given as the mean  standard deviation (SD) or as the
median and range. The Chi-square test or Fisher’s exact test was used
to compare dichotomous variables, and the t-test or Mann–Whitney
test was used for continuous variables, as appropriate. The associa-
tions of clinical and laboratory features with the outcome were
analyzed by univariate and multivariate logistic regression and 95%
conﬁdence intervals (95% CI) were calculated. For all tests, a two-
sided p-value of 0.05 or less was considered statistically signiﬁcant.
3. Results
3.1. Clinical proﬁle
The study cohort consisted of 154 cases of proven scrub typhus
admitted during the study period. The mean age of the patients
was 46  15 years, and there was a slight male predominance (81
males, 54%). The majority (77%) were agricultural workers and
housewives. Common symptoms included fever, breathlessness,
cough, nausea and vomiting, headache, and myalgia (Table 1). The
mean duration of fever prior to presentation was 9  3 days. An
eschar was present in 86 (55%), with common sites including the
groin, axilla, neck, and breast folds.
3.2. Organ dysfunction and outcome (Table 2)
The majority of patients had some form of respiratory
complaint on admission, with more than 60% reporting shortness
of breath, 37% cough, and tachypnea being observed in nearly
three-quarters (71.4%). An abnormal chest radiograph was evident
in 61%. Acute respiratory distress syndrome (ARDS) was diagnosed
Table 1
Patient characteristicsa
Patient characteristics Alive, n = 142 (92.2%) Dead, n = 12 (7.8%) p-Value
Age, years 45.14  15.2 50.3  12.8 0.18
Sex, male:female 76:66 5:7 0.5
Duration of illness before admission, days 9.7  3.8 7.3  2.5 0.04
Occupation
Farmer 68 (47.9) 3 (25) 0.14
Housewife 42 (29.6) 6 (50) 0.19
Other 32 (22.5) 3 (25) 1.00
Co-morbidities
Diabetes mellitus 21 (14.8) 1 (8.3) 1.00
Hypertension 18 (12.7) 5 (41.7) 0.02
COPD/asthma 5 (3.5) 0 (0) 1.00
Chronic renal failure 1 (0.7) 0 (0) 1.00
Pregnancy 2 (1.4) 1 (8.3) 0.21
Headache 63 (44.4) 3 (25) 0.24
Altered sensorium 34 (23.9) 4 (33.3) 0.47
Seizures 9 (6.3) 1 (8.3) 0.78
Nausea/vomiting 77 (54.2) 6 (50) 1.00
Myalgia 47 (33.1) 3 (25) 0.75
Diarrhea 17 (12) 3 (25) 0.19
Cough 53 (37.3) 4 (33.3) 1.00
Shortness of breath 82 (57.7) 12 (100) 0.004
Rash 2 (1.4) 0 (0) 1.00
Eschar 78 (54.9) 8 (66.7) 0.55
Tachypnea 99 (69.7) 11 (91.7) 0.18
Investigations
Heart rate/min 102  17 114.8  20.9 0.02
Systolic blood pressure, mmHg 108.8  15.8 106.6  16.6 0.55
Hemoglobin, g/dl 12  1.7 12.5  1.9 0.36
WBC count, 109/l 10.4 (1.2–36.6) 14.4 (7.7–36.0) 0.001
Platelet count, 109/l 79.0 (3.0–368.0) 38.0 (15.0–98.0) 0.03
Bilirubin (mg/dl) 1.1 (0.4–14.6) 2.25 (0.5–8.2) 0.4
Total protein (g/dl) 6.4  0.7 5.8  0.8 0.09
Albumin (g/dl) 2.7  0.5 2.4  0.5 0.07
AST (IU/l) 132 (14–752) 201 (88–325) 0.25
ALT (IU/l) 70 (10–312) 65 (30–117) 0.47
ALP (U/l) 151 (44–715) 200 (83–403) 0.52
Serum creatinine (mg/dl) 1.1 (0.5–6.6) 2.2 (0.6–8.6) 0.001
Creatinine phosphokinase 94 (21–3010) 261 (82–2172) 0.03
Abnormal chest X-ray 83 (58.5) 11 (91.7) 0.03
COPD, chronic obstructive pulmonary disease; WBC, white blood cell count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase.
a Values are given as the mean  standard deviation or median (range), as appropriate, for continuous variables, and as the number (percentage) for discrete variables.
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days.
Gastrointestinal and hepatic involvement was common. More
than half of the patients (53.9%) complained of nausea and
vomiting at the time of admission, with a minority having diarrhea
(13.0%). There was also evidence of liver involvement, with a mild
transaminitis (elevation to 2–3 times normal) in 72.5% and an
elevated bilirubin in 26.6%.
Central nervous system manifestations were not uncommon.
Headache was documented in 66 (42.8%) patients, an altered
sensorium in 38 (24.6%), and seizures in only 10 (6.5%) patients.
Aseptic meningitis or meningoencephalitis was diagnosed in 29
(18.8%) patients.
An elevated creatinine of >2.5 mg/dl was observed in 20
(12.9%) patients, with about a quarter requiring dialysis. Hypo-
tension with a need for vasoactive agents was seen in 38 (24.6%)Table 2
Complications
Complication No. (%) Alive (%)
ARDS 67 (43.5) 58 (40.8
Shock requiring vasoactive agents 38 (24.6) 29 (20.4
Hepatitis (bilirubin 2.5 mg/dl) 99 (64.2) 91 (64.1
Meningoencephalitis 29 (18.8) 29 (20.4
Renal failure (creatinine 2.5 mg/dl) 20 (12.9) 15 (10.6
MODS 59 (38.3) 48 (33.8
CI, conﬁdence interval; ARDS, acute respiratory distress syndrome; MODS, multiple orpatients. Over a third of patients (38.3%) had evidence of multi-
organ dysfunction. The overall in-hospital mortality was 7.8%, but
in the majority of patients who survived (65.5%) there was a
dramatic response to doxycycline therapy, with the mean time to
defervescence being 2  0.8 days.
3.3. Predictors of mortality
The predictors of mortality were explored using univariate and
multivariate analysis (Table 3). The presence of an eschar did not
have a statistically signiﬁcant impact on mortality, nor did pre-
existing medical conditions such as diabetes mellitus, hyperten-
sion, asthma/chronic obstructive pulmonary disease, or chronic
renal failure. On univariate analysis, the factors associated with
mortality included the presence of jaundice (p = 0.02), hypotension
requiring vasoactive agents (p = 0.001), ARDS (p = 0.02), need for Dead (%) p-Value RR (95% CI)
) 9 (75) 0.03 4.3 (1.1–16.7)
) 9 (75) 0.001 11.6 (2.9–45.9)
) 8 (66.7) 0.29 1.9 (0.56–6.3)
) 0 (0) 0.9 -
) 5 (41.7) 0.005 6.04 (1.7–21.4)
) 11 (91.7) 0.004 21.5 (2.7–171.7)
gan dysfunction syndrome; RR, Relative Risk.
Table 3
Predictors of mortality
Alive, n = 142 (92.2%) Dead, n = 12 (7.8%) RR (95% CI) p-Value
Altered sensorium 34 (23.9) 4 (33.3) 1.6 (0.45–5.6) 0.5
Duration of illness, days 9.7  3.8 7.3  2.5 0.82 (0.67–0.99) 0.04
Seizures 9 (6.3) 1 (8.3) 1.3 (0.16–11.6) 0.78
SOB 82 (57.7) 12 (100) 1.14 (1.06–1.2) 0.99
Jaundice 36 (25.7) 7 (58.3) 4.04 (1.2–13.5) 0.02
Presence of eschar 78 (54.9) 8 (66.7) 0.61 (0.17–2.1) 0.43
Heart rate/min 102  17 114.8  20.9 1.04 (1.006–1.07) 0.02
Systolic BP 90 mmHg 23 (16.2) 3 (25) 1.7 (0.43–6.8) 0.43
WBC count, 109/l 10.4 (1.2–36.6) 14.4 (7.7–36.0) 0.99 (0.99–0.99) 0.01
Platelet count, 109/l 79.0 (3.0–368.0) 38.0 (15.0–98.0) 0.99 (0.99–0.99) 0.04
Bilirubin (mg/dl) 1.1 (0.4–14.6) 2.25 (0.5–8.2) 1.08 (0.9–1.3) 0.4
Bilirubin 2.5 mg/dl 36 (25.4) 5 (41.7) 1.9 (0.57–6.4) 0.29
AST (IU/l) 132 (14–752) 201 (88–325) 1.003 (0.99–1.008) 0.25
ALT (IU/l) 70 (10–312) 65 (30–117) 0.99 (0.98–1.007) 0.47
ALP (U/l) 151 (44–715) 200 (83–403) 1 (0.99–1.006) 0.52
ARDS 58 (40.8) 9 (75) 4.3 (1.1–16.7) 0.03
Hypotension requiring vasoactive agents 29 (20.4) 9 (75) 11.7 (2.9–45.9) 0.001
Serum creatinine (mg/dl) 1.1 (0.5–6.6) 2.2 (0.6–8.6) 1.75 (1.25–2.47) 0.001
Serum creatinine 2.5 mg/dl 15 (10.6) 5 (41.7) 6.04 (1.6–13.6) 0.005
Meningoencephalitis 29 (20.4) 0 (0) 0.00 (0.00–0.00) 0.99
Ventilatory support 42 (29.6) 10 (83.3) 11.9 (2.5–56.6) 0.002
Duration of ventilation 0 (0–17) 1 (0–17) 1.06 (0.89–1.25) 0.85
MODS 48 (33.8) 11 (91.7) 0.05 (0.006–0.37) 0.004
Genotype
Kato-like 16 (66.6) 1 (8.3) 1.4 (0.14–15.4) 0.8
Karp-like 7 (29.1) 1 (8.3)
Gilliam 1 (4.1) 0 (0)
RR, relative risk; CI, conﬁdence interval; SOB, shortness of breath; BP, blood pressure; WBC, white blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase;
ALP, alkaline phosphatase; ARDS, acute respiratory distress syndrome; MODS, multiple organ dysfunction syndrome.
a Values are given as the mean  standard deviation or median (range), as appropriate, for continuous variables, and as the number (percentage) for discrete variables.
Figure 1. 56-kDa antigen PCR. Lane 1: 100-bp ladder; lane 2: OTV1; lane 3: OTV2;
lane 4: OTV4; lane 5: OTV5; lane 6: OTV6. Orientia strains isolated from Vellore are
designated as OTV. Non-speciﬁc primer binding due to hypervariability in the
region could be a possible explanation for the double band seen in lane 3.
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creatinine greater than 2.5 mg/dl (p = 0.006). The duration of
symptoms and duration of ventilation tended to be higher in non-
survivors. Hypotension requiring vasoactive agents was found to
be an independent predictor of mortality (relative risk 11.5, 95% CI
2.9–45.15; p < 0.001) on multivariate analysis using the forward
method, with signiﬁcant variables of jaundice, renal failure, ARDS,
and hypotension requiring vasoactive agents.
3.4. Genotyping data
The 410-bp region of the 56-kDa TSA was ampliﬁed from the
collected samples (Figure 1), and 26 representative amplicons
were sequenced and compared with isolates from other regions of
Asia. On phylogenetic and sequence analysis, 17 strains (65%)
clustered with the Kato group, eight (35%) clustered with Karp-like
isolates, and one with the Gilliam stain (Figure 2). The majority of
the isolates showed a 95–98% sequence similarity with O.
tsutsugamushi isolates from Vietnam and Cambodia. Eighty-one
percent of the Kato-like isolates showed 90–95% similarity to the
Hualein 3 isolate from Taiwan. The genetic variations of this small
number of sequences did not have any signiﬁcant association with
the outcome.
4. Discussion
Scrub typhus affects almost a million people every year and
mainly occurs in populations that encounter scrub vegetation as
part of their occupation or daily life.21 The disease, which had been
known to be endemic in these regions, was lost from the radar of
the scientiﬁc community until recently, probably due to the
widespread use of pesticides, empiric chloramphenicol and
tetracycline use for acute febrile illnesses, and changes in lifestyle.
However, the disease is now clearly documented to have
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cases of scrub typhus admitted to a tertiary care hospital, over a
third of patients had multi-organ dysfunction, resulting in a case
fatality of 7.8%. Hypotension requiring vasoactive agents was
found to be an independent predictor of mortality, and the
phylogenetic analysis revealed Kato-like and Karp-like strains to
be the predominant circulating ones.Figure 2. Phylogenetic analysis of isolates using the neighbor-joining method.
The evolutionary history was inferred using the neighbor-joining method. The
evolutionary distances were computed using the maximum composite likelihood
method, and the percentage of replicate trees that clustered together using
the bootstrap test are shown next to the branches. The analysis involved 46
nucleotide sequences. Codon positions included are 1st + 2nd + 3rd + non-coding. All
positions containing gaps and missing data were eliminated. A total of 353 positions
were included in the ﬁnal dataset. Evolutionary analyses were conducted in
MEGA5.204.1. General ﬁndings
Scrub typhus has previously been found to account for up to
50% of undifferentiated febrile illness occurring in this part of India
during the cooler months of the year,23 and cases have also been
reported from Tamil Nadu, Kerala, Maharashtra, Bihar, Karnataka,
Jammu and Kashmir, Uttaranchal, Rajasthan, West Bengal, and
Meghalaya.3,5,24,25 Most of the symptoms of scrub typhus are non-
speciﬁc in nature, including fever, breathlessness, nausea, head-
ache, vomiting, and myalgia, and do not show much variation
among subjects in different studies. However, the presence of the
eschar shows considerable variation. An eschar prevalence of up to
90% was reported from Korea.26 Mahajan et al., however, found the
incidence of the eschar in northern India to be far lower at only
9.5%.3 The incidence of eschar in our study was 55%, which is
consistent with prior ﬁndings of Vivekanandan et al., who found an
incidence of 46% in a hospital near the same geographic
locations.19 Overall, an eschar may be a highly variable ﬁnding,
found in anywhere from 10% to 92% of patients with scrub typhus,
but may not be found, even when present, unless thoroughly
searched for.27 In the present study, the absence of an eschar was
not a predictor of mortality, as has been shown in other studies.26
In fact, though not statistically signiﬁcant, there was a trend
towards a direct correlation between the ﬁnding of an eschar and
mortality.
Similarly, jaundice on presentation was found to predict
mortality. However, liver function tests were not signiﬁcantly
different between those who survived and those who did not. It is
unclear what the signiﬁcance of these ﬁndings are, possibly
representing a search bias on presentation, with more attention
paid, thus more physical ﬁndings noted, in sicker patients.
4.2. Complications
In addition to variations in eschar ﬁndings, reports of
laboratory ﬁndings and serious complications vary signiﬁcantly.
Previous studies from India have shown an incidence of ARDS of
8–10%,3,19 while our data showed 43.5% of patients with evidence
of ARDS. This was a predictor of mortality, as shown in previous
studies.5 We found evidence of hepatocellular involvement in
64.2% of our patients, while an earlier study from India has
reported an even higher percentage of patients (95.9%) with
elevated liver enzymes.19 The incidence of renal impairment was
13% in this study, which is similar to results obtained by
Vivekanandan et al.,19 but much lower than the 66.4% reported
by Mahajan et al.3 Meningitis and meningoencephalitis were
found more often in our study population, with an incidence of
18.8%, compared to prior studies in India, where these were
reported at 14% and 9.5%.3,19 An altered sensorium, however, was
not associated with mortality in our study, as has previously been
described.5,26
4.3. Mortality
In our study, the overall case fatality rate was 7.8%. Rates of
fatality have shown considerable variation between studies,
though the reasons for this have not been extensively studied.
Even within India, these rates have varied considerably, with the
previously mentioned cases from Pondicherry having only a 2%
case fatality,19 while most studies have shown somewhat higher
rates. Overall there is potentially a trend towards a decreasing
mortality from this infection, as reports of a scrub typhus outbreak
in northern India in 2004 documented a mortality rate of 17.2%,
which subsequently decreased to 14% in 2006.3,28 This correlates
well with the trend in our data, which previously showed a case
fatality rate of 14% in 2003.6
Table 4
Prevalence of genotypes at various geographic locations
South India Taiwan12,39 Vietnam15 Cambodia15 Thailand32 Korea34 Japan35 China36–38
Kato-like (65.3%) Gilliam (50%) Karp (77%) Karp (43.5%) Karp-like (65%) Boryong (70–80%) Kuroki (47.5%) Gilliam (91%)
Karp-like (30.7%) Kawasaki/Karp (45%) TA763 (15.5%) Kato (21.5%) Gilliam-like (22%) Kawasaki (25%) Kawasaki (42.5%) Karp (9–23%)
Gilliam (3.8%) Kuroki (14.7%) JGva (7.5%) Gilliam (3.5%) TA716 (4%) Karp (2–3%) Karp (10.0%) Karp mix (72%)
a Japanese Gilliam variant.
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The 56-kDa TSA protein is the most abundant protein of
Orientia and contains both unique and cross-reacting epitopes. It is
responsible for the genetic diversity of Orientia tsutsugamushi.11,29
Diagnostically, using PCR to look for the 56-kDa protein gene in an
eschar is an efﬁcient method in the early stages of illness, as
conﬁrmed by several studies. A nested PCR to detect the 56-kDa
gene has been reported in several studies, but the use of
conventional PCR has not been as well investigated.17,29 Conven-
tional PCR was found to have a good correlation with nested PCR
and has been reported to be useful for molecular diagnostics.17,30
Using conventional PCR, we found that the isolates in our study
clustered in the Karp-like (30.7%) and Kato-like (65%) groups and
showed sequence similarity to isolates from Korea, Taiwan,
Vietnam, and Cambodia. An increased prevalence of Karp and
Karp-like strains has been reported in the Southeast Asian
countries, including Malaysia (56%), Thailand (65%), Myanmar
(46%), and Philippines (78%).31–33 Other studies from India have
already reported two new genotypes, including one genetically
between the Karp and JP-1 types, and another between Saitama
and JG types, in addition to Kato, Kawasaki, and Karp type isolates.3
Boryong is the predominant strain reported from Korea, while
studies from Japan and China have shown a mixture of many
strains, which differ between the prefectures.34,35 Several other
studies have reported the prevalence of major genotypes
circulating in various endemic geographical locations
(Table 4).12,15,32,34–39 Australia and Taiwan have shown a very
high incidence of the TA716 strain,39,40 and seasonal strain
variations have been demonstrated in Chinese and Taiwanese
studies.12,41 Information on the geographical spread of this disease
would be helpful for clinicians suspecting possible scrub typhus in
a patient. Additionally, knowledge of the geographic distribution of
the various disease strains will be vital for the production of future
diagnostic tests and vaccines. Although there was no signiﬁcant
association between the genotype and the outcome in this study,
probably due to the small sample size, future studies looking at this
question using a larger sample, powered to detect the difference,
would be helpful.
Since this study was conducted in a large university teaching
hospital, the inherent referral bias may overestimate the rates of
complications. The other limitation is that of the admission
diagnosis based on a single serological test. However, up to 10%
false-positivity and false-negativity of this test is clinically
acceptable in practice.
4.5. Conclusions
Scrub typhus can be a very serious infection that often presents
with non-speciﬁc symptoms, making it difﬁcult to differentiate
from other infections. The laboratory ﬁndings and clinical course
may also vary signiﬁcantly, making diagnosis and appropriate
treatment difﬁcult. Jaundice, renal failure, ARDS, and hypotension
requiring vasoactive agents are predictors of mortality, with
hypotension requiring vasoactive agents being independently so.
Strain variations may contribute to the variation in presentation,
and so further data correlating strain with clinical presentationwould be useful for focusing research on appropriate vaccine
candidates. Prompt diagnosis and treatment is essential as a delay
in treatment can result in signiﬁcant mortality, and the develop-
ment of further point-of-care diagnostics could signiﬁcantly aid
this. The prevalent genotypes in our study were those in the Kato
and Karp groups. However, given the broad variation seen in the
strains of other countries, further prospective epidemiological and
molecular studies will be required to identify the prevalent strains
and their antigenic variations in this area.
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